Company intelligence / Profile preview

3rd Millennium

Cambridge, MA, USA

Ownership: Private
Employees: ~25
Development stage: Other

Overview

3rd Millennium is a specialized bioinformatics and IT consulting firm that provides data management and software solutions to the life sciences sector. Established in 1996, the company focuses on helping pharmaceutical and biotechnology organizations manage, analyze, and integrate complex biological and clinical data. Their services include custom pipeline development, cloud computing transitions, and the implementation of enterprise-level research platforms. 3rd Millennium was acquired by Constellation Software in 2014 and operates within its Vela Software division, continuing to serve global research institutions and commercial drug developers.

Industry: Consulting

Beyond the preview

Go deeper on 3rd Millennium.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on 3rd Millennium.

Explore the full profile